Thalidomide Induces Granuloma Differentiation in Sarcoid Skin Lesions Associated with Disease Improvement
- 1 March 2002
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 102 (3) , 225-236
- https://doi.org/10.1006/clim.2001.5173
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Thalidomide Stimulates T Cell Responses and Interleukin 12 Production in HIV-Infected PatientsAIDS Research and Human Retroviruses, 1999
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- Cutaneous Sarcoidosis Successfully Treated With Low Doses of ThalidomideArchives of Dermatology, 1998
- Interleukin-12: An Immunoregulatory Cytokine Produced by B Cells and Antigen-Presenting CellsMethods, 1997
- Role of Tl and T2 Cytokines in the Response to Mycobacterium tuberculosisAnnals of the New York Academy of Sciences, 1996
- Treatment of cutaneous and pulmonary sarcoidosis with thalidomideJournal of the American Academy of Dermatology, 1995
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.Journal of Clinical Investigation, 1988
- Skin tests in sarcoidosisTubercle, 1957
- The Mumps Skin Test and Complement Fixation Test as a Diagnostic Aid in SarcoidosisJournal of Investigative Dermatology, 1955